HUTCHMED (China) Ltd Files 6-K Report

Ticker: HMDCF · Form: 6-K · Filed: Oct 2, 2025 · CIK: 1648257

Hutchmed (China) LTD 6-K Filing Summary
FieldDetail
CompanyHutchmed (China) LTD (HMDCF)
Form Type6-K
Filed DateOct 2, 2025
Risk Levellow
Pages1
Reading Time1 min
Sentimentneutral

Sentiment: neutral

Topics: regulatory-filing, corporate-update

TL;DR

HUTCHMED (China) Ltd filed a 6-K on Oct 2, 2025, confirming 20-F annual reports.

AI Summary

HUTCHMED (China) Limited, formerly Hutchison China MediTech Ltd, filed a Form 6-K on October 2, 2025. This report is for the month of October 2025 and indicates the company files annual reports under Form 20-F. The company is based in Hong Kong and operates in the Pharmaceutical Preparations industry.

Why It Matters

This filing provides routine updates for investors and regulatory bodies regarding HUTCHMED's reporting status and corporate information.

Risk Assessment

Risk Level: low — This is a routine administrative filing and does not contain new financial or operational information that would typically increase risk.

Key Players & Entities

FAQ

What is the primary purpose of a Form 6-K filing?

A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to provide information that the company may be required to disclose or make public in its home country.

What is HUTCHMED (China) Limited's former name?

HUTCHMED (China) Limited's former name was Hutchison China MediTech Ltd.

On what date was this Form 6-K filed?

This Form 6-K was filed on October 2, 2025.

Does HUTCHMED (China) Limited file annual reports under Form 20-F or 40-F?

HUTCHMED (China) Limited files annual reports under cover of Form 20-F.

Where is HUTCHMED (China) Limited's principal executive office located?

HUTCHMED (China) Limited's principal executive office is located at 48th Floor, Cheung Kong Center, 2 Queen's Road Central, Hong Kong.

Filing Stats: 167 words · 1 min read · ~1 pages · Grade level 13.1 · Accepted 2025-10-02 06:37:03

Filing Documents

From the Filing

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of Octo ber 2025 Commission File Number: 001-37710 HUTCHMED (CHINA) LIMITED (Translation of registrant's name into English) 48th Floor, Cheung Kong Center, 2 Queen's Road Central, Hong Kong (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F HUTCHMED (CHINA) LIMITED Form 6-K EXHIBIT INDEX Exhibit No. Description Exhibit 99.1 Press release relating to clinical data to be presented at the ESMO Congress 2025 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. HUTCHMED (CHINA) LIMITED By: /s/ Johnny Cheng Name: Johnny Cheng Title: Chief Financial Officer Date: October 2, 2025 3

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing